Further investigation is necessary to grasp the complete advantages of semaglutide and similar GLP-1 medications
In the PIONEER 2 trial, patients taking Rybelsus lost an average of 4.7 kg (10.4 lbs) at 52 weeks, which was significantly greater than Jardiance (p=0.0114)
Offered at our Wellington clinic, conveniently serving patients from Royal Palm Beach, Century Village, Wellington, and Lake Worth
NEW DELHI: In good news for those suffering from obstructive sleep apnea (OSA), a condition characterised by disordered breathing during sleep, the US FDA has, for the first time, approved an anti-diabetic drug also used for weight loss, sold under the brand name Zepbound (Tirzepatide), to manage the condition in adults with obesity.Treatments currently for moderate to severe OSA involve using assistive breathing devices such as CPAP and Bi-Pap
PMID: 30349609